Quantification of Paroxetine in Human Plasma by Liquid Chromatography Coupled with Electrospray Ionization Tandem Mass Spectrometry

被引:0
作者
Shah, Hiten J. [1 ,2 ]
Kundlik, Mohan L. [1 ]
Kakad, Abhijit [1 ]
Patel, Nitesh K. [1 ]
Pandya, Ankit [1 ]
Khatri, Vanita [1 ]
Prajapati, Shivkumat [1 ]
Subbaiah, Gunta [1 ]
Patel, Chhagan N. [2 ]
机构
[1] Torrent Res Ctr, Bioanalyt Lab, Gandhinagar 382428, Gujarat, India
[2] Shri Sarvajanik Pharm Coll, Mehsana 384001, Gujarat, India
关键词
GAS-CHROMATOGRAPHY; FLUORESCENCE DETECTION; METABOLITES; PHARMACOKINETICS; HPLC; DEPRESSION; CITALOPRAM; VALIDATION;
D O I
暂无
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
A rapid LC coupled with electrospray ionization (ESI) MS/MS method was developed and validated for the quantification of paroxetine in heparinized human plasma. The plasma samples were prepared by the solid-phase extraction method without drying or reconstitution. Elution was done with 0.5 mL 0.2% (v/v) formic acid in methanol-acetonitrile (65 + 35, v/v). The analyte and the internal standard (IS; imipramine hydrochloride) were chromatographed on a BDS Hypersil C18 column. The analyte was analyzed by LC/MS/MS with only 1.7 min run time. An ESI interface was chosen for ionization of the analyte from the sample matrix. Selected reaction monitoring mode for detection of paroxetine and the IS were achieved by using m/z 330.17/192.10 and 281.13/86.14, respectively. The LC retention times for paroxetine and imipramine were 0.94 and 1.05 min, respectively. The method was linear in the concentration range of 0.5-80.0 ng/mL with r >= 0.9995. Recovery of paroxetine and imipramine ranged from 90 to 95%. The assay has been successfully applied to bioequivalence study samples for estimation of paroxetine in healthy human subjects.
引用
收藏
页码:141 / 149
页数:9
相关论文
共 28 条
[1]   Spectrofluorimetric determination of paroxetine hydrochloride in its formulations and human plasma [J].
Alarfaj, N ;
Razeq, SA ;
Sultan, M .
CHEMICAL & PHARMACEUTICAL BULLETIN, 2006, 54 (04) :564-566
[2]   Use of paroxetine for the treatment of depression and anxiety disorders in the elderly: A review [J].
Bourin, M .
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2003, 18 (03) :185-190
[3]   DETERMINATION OF PAROXETINE IN HUMAN-PLASMA, USING HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH FLUORESCENCE DETECTION [J].
BRETT, MA ;
DIERDORF, HD ;
ZUSSMAN, BD ;
COATES, PE .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1987, 419 :438-444
[4]  
CALULL CL, 1999, J CHROMATOGR B, V724, P393
[5]   PHARMACOKINETICS OF PAROXETINE IN PATIENTS WITH CIRRHOSIS [J].
DALHOFF, K ;
ALMDAL, TP ;
BJERRUM, K ;
KEIDING, S ;
MENGEL, H ;
LUND, J .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 41 (04) :351-354
[6]   Determination of emtricitabine in human plasma using HPLC with fluorometric detection [J].
Droste, J. A. H. ;
Aarnoutse, R. E. ;
Burger, D. M. .
JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES, 2007, 30 (18) :2769-2778
[7]   Simultaneous determination of human plasma levels of citalopram, paroxetine, sertraline, and their metabolites by gas chromatography mass spectrometry [J].
Eap, CB ;
Bouchoux, G ;
Amey, M ;
Cochard, N ;
Savary, L ;
Baumann, P .
JOURNAL OF CHROMATOGRAPHIC SCIENCE, 1998, 36 (07) :365-371
[8]   Quantitative determination of paroxetine in plasma by high-performance liquid chromatography and ultraviolet detection [J].
Foglia, JP ;
Sorisio, D ;
Kirshner, M ;
Pollock, BG .
JOURNAL OF CHROMATOGRAPHY B, 1997, 693 (01) :147-151
[9]   Time course of response to paroxetine: Influence of plasma level [J].
Gex-Fabry, Marianne ;
Gervasoni, Nicola ;
Eap, Chin B. ;
Aubry, Jean-Michel ;
Bondolfi, Guido ;
Bertschy, Gilles .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2007, 31 (04) :892-900
[10]   METABOLIC PATHWAY OF PAROXETINE IN ANIMALS AND MAN AND THE COMPARATIVE PHARMACOLOGICAL PROPERTIES OF ITS METABOLITES [J].
HADDOCK, RE ;
JOHNSON, AM ;
LANGLEY, PF ;
NELSON, DR ;
POPE, JA ;
THOMAS, DR ;
WOODS, FR .
ACTA PSYCHIATRICA SCANDINAVICA, 1989, 80 :24-26